Surveillance of antibiotic resistance in non invasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winters 2003 and 2004

Acta Clinica Belgica

Volumn 61, Issue 2, 2006, Pages 49-57

  Vanhoof, R ^a   Carpentier, M ^b   Cartuyvels, R ^c   Damee S ^a   Fagnart, O ^d   Frans, J ^e   Gordts, B ^f   Glupczynski, Y ^g   Goffinet, P ^h   Govaerts, D ⁱ   Lefevre Ph ^j   Lontie, M ^k   Magerman, K ^c   Mans, I ^a   Meunier, F ^l   Moonens, F ^m   Surmont, I ⁿ   Van Bossuyt, E ^a   Van De Vyvere, M ^o   Van Eldere, J ^p   Van Landuyt, H ^f   Van Nimmen, L ^q   Van Noyen, R ^e   Verhaegen, J ^p   more..

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b Centre Hospitalier Regional de La Citadelle   (Belgium)

^c VIRGA JESSE HOSPITAL   (Belgium)

^d Clinique Saint Etienne   (Belgium)

^e IMELDA HOSPITAL   (Belgium)

^f General Hospital St Jan   (Belgium)

^g UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^h Laboratoire de Microbiologie   (Belgium)

ⁱ CHU Andre Vesale   (Belgium)

^j Hospital Princess Paola   (Belgium)

^k Medisch Centrum Huisartsen   (Belgium)

^l Hospital de Jolimont   (Belgium)

^m Clinique Louis Caty   (Belgium)

ⁿ Heilig Hart Ziekenhuis   (Belgium)

^o Stuivenberg General Hospital   (Belgium)

^p UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^q Algemeen Ziekenhuis Jan Palfijn   (Belgium)

more..

Author keywords

Resistance; S. pneumoniae; Surveillance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM; CEFACLOR; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; CLINDAMYCIN; ERTAPENEM; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE;

ARTICLE; BELGIUM; DRUG RESISTANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIA; WINTER;

EID: 33646772226     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2006.010     Document Type: Article

References (17)

1. Brueggemans AB, Coffmann SL, Rhomberg P, et al. Fluoroquinolone resistance in Streptococcus pneumoniae in the United States since 1994-1995. Antimicrob Agents Chemother. 2002; 46: 680-8.
2. Ho PL, Yung RWH, Tsang DNC, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong-Kong multicentre study in 2000. J Antimicrob Chemother. 2001; 48: 659-65.
3. Hoban DJ, Bouchillon SK, Karlowsky JA, et al. A comparative in vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. Antimicrob Agents Chemother. 2000; 44: 3008-11.
4. Kristinsson KG. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 1997; 3: 117-23.
5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 1997. NCCLS Document M7-A4, vol. 17 No. 2, Villanova, PA.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 2005. NCCLS Document M100-S15, Vol. 25, No. 1, Wayne PA.
7. Pérez-Trallero E, Garcia-de-la-Fuente C, Garcia-Ray C, et al. Geographical and ecological analysis of resistance, co-resistance, and coupled resistance to antimicrobials in Respiratory pathogenic bacteria in Spain. Antimicrob. Agents Chemother. 2005; 49: 1965-72.
8. Regev-Yochay G, Raz M, Shainberg B, et al. Independent risk factors for carriage of penicillin non susceptible Streptococcus pneumoniae. Scand. J. Infect. Dis. 2003; 35: 219-22.
9. Sahm DF, Karlowsky JA, Kelly LJ, et al. Kahn. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob. Agents Chemother. 2001; 45: 1037-42.
10. Vanhoof R, Christiaens F, Dierickx R, Coignau H, Butzler JP. In vitro evaluation of the antibiotic susceptibility of Streptococcus pneumoniae: pneumococci relatively resistant to penicillin in Brussels. Acta Clin Belg. 1980; 35: 343-8.
11. Vanhoof R, Carpentier M, Glypczynski Y, et al. In vitro susceptibility of 176 clinical isolates of Streptococcus pneumoniae to 11 β-lactams, erythromycin ad tetracycline. Acta Clin Belg. 1996; 51: 377-85.
12. Vanhoof R, Carpentier M, Glypczynski Y, et al. Surveillance of pneumococcal resistance in Belgium during winter 1996-1997. Acta Clin Belg. 1998; 53: 275-81.
13. Vanhoof R, Carpentier M, Fagnart O, et al. In vitro study of the antimicrobial activity of various antibiotics against clinical isolates of Streptococcus pneumonias from Belgium collected during winter 1998-1999. Acta Clin Belg. 2000; 55: 312-21.
14. Vanhoof R, Carpentier M, Cartuyvels R, et al. Surveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001. Acta Clin Belg. 2003; 58: 111-9.
15. Verhaegen J, Vandeven J, Verbiest N, Van Eldere J, Verbist L. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium - update (1994-98). Clin Microbiol Infect. 2000; 6: 308-15.
16. Verhaegen J. Streptococcus pneumoniae. In: Ducoffre G, Ed. Surveillance van infectieuze aandoeningen door een netwerk van laboratoria voor Microbiologie 2003 + epidemiologische trends 1983-2002. IPH/EPI Reports Nr. 2004-019; Depot number D/2004/2505/21.
17. Verhaegen J, Verbist L. In-vitro activities of 16 non-β-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother. 1999; 43: 563-7.